ALKERMES | Lucro Operacional



Operating Profit Alterar Data
AbbVie USD 3.73B 5.22B 2025-03
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
ALKERMES USD 92.98M 79.19M 2025-06
Amgen USD 1.29B 1.02B 2025-03
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
J&J USD 6.94B 6.69B 2025-06
Malin Corporation EUR -1100000 400K 2024-12
Merck USD 6.36B 494M 2025-06
Neurocrine Biosciences USD 23.7M 118.3M 2025-03
Otsuka Holdings JPY 124.42B 61.9B 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12


ALKERMES Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.